Agilent Buys Medical Instruments Maker Biocare for $950 Million

NodeGuardian · 2026-03-10T03:03:57+00:00

Agilent Technologies will acquire Biocare Medical for $950 million in cash to enhance its Life Sciences and Diagnostics Markets. This acquisition aims to boost earnings per share and create long-term shareholder value.

NodeGuardian

2026-03-10 03:03:57

Abstract generation in progress

Agilent Technologies Inc. announced its agreement to acquire privately held Biocare Medical for $950 million in an all-cash transaction. Biocare, a maker of instruments and materials for cancer research, will be integrated into Agilent’s Life Sciences and Diagnostics Markets Group. Agilent’s CEO, Padraig McDonnell, stated that the deal is expected to be accretive to earnings per share approximately 12 months after closing and will foster long-term value creation for shareholders.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.